|
There seems to be no limit to what
injection moulding is capable of. With the varied
injection moulding processes available, seemingly any
plastic article can be conjured up, however complex
the geometry. Such specialised innovative methods as
co-injection, in-mould decoration, insert moulding,
foam injection moulding, gas- and water-assisted
injection moulding, combined processes, thin-wall
technology and, increasingly, micro- and
nanotechnology help to satisfy the wide-ranging needs
of the various user industries.
Injection-moulded plastic parts are
part and parcel of everyday life. Be they mobile phone
casings, beverage crates, toy figures, gearwheels for
adjustment mechanisms, bumpers on cars, drinking cups,
CDs and DVDs, or syringe bodies in medical technology,
injection mouldings are encountered everywhere in all
sizes, ranging from a few micrograms to several
kilograms. Uniting several components in a single
injection moulding, integrating as many functions as
possible in a single component, and converting
production methods comprising several steps into a
single-stage process – these are the chief innovation
goals in the injection moulding sector.
It is in medical technology above
all that injection moulding offers scope for endless
possibilities. Along with ongoing progress in process
engineering, the development of new types of materials
is opening up additional fields of application.
Sterilisability, biocompatibility, antimicrobial
finishes, special barrier properties, nano- and
microsystems technology, and biodegradable and
absorbable materials are just some of the key areas in
which materials developers are advancing progress in
this vital field. Medical technology will continue to
be a sector with an exciting future and a driving
force for wide-ranging innovation.
However, anyone wanting to gain a
foothold in medical technology has to be not only
innovative and engage in high-quality and
cost-effective production, but also master the
guidelines that additionally apply in this sector.
Safety Across The Board
Compared to other sectors, the
standard of quality and documentation here is
outstanding. Production to GMP guidelines is a must.
Continuous monitoring, compliance with the hygiene
regulations and the full documentation of all process
data over a period of years is integral to these
guidelines. In view of these requirements, the status
of component supplier to medical technology obviously
is not something that can be acquired overnight. “The
rules that apply here have to be mastered and embraced
throughout the company organisation. Smaller
companies, in particular, are often at a disadvantage
in that they cannot afford to go to these lengths.
However, anyone who gains a foothold here has a pretty
secure position, because switching suppliers also
involves a high degree of regulatory effort,” says
Christoph Brand, General Manager of Polymec AG in
Langendorf, Switzerland, explaining the situation from
the point of view of a supplier certified to ISO
13485.

Injection mouldings are
vital helpers in medical technology.
Image: B. Braun Melsungen AG
Under these conditions, it goes
without saying that product development takes place in
extremely close cooperation between the medical
technology or pharmaceutical company on the one hand
and the supplier on the other. Systems suppliers are
in a strong position particularly on this market.

These components for a
breath-controlled dry-powder inhaler were produced by
systems supplier Balda Medical GmbH & Co. KG for ac-Pharma
using POM and PBT materials from Ticona.
Numerous suppliers provide a full
one-stop service covering everything from the
development and production of the injection moulds to
the injection moulding process itself and the
assembly, packaging and inspection of the medical
technology products.
Cleanliness From Start
To Finish
The production of medical and
pharmaceutical injection mouldings is closely
associated with cleanroom technology. Whether these
are single-use products such as syringes and pipette
tips or functional components such as inhalers, the
demand is always for hygienically impeccable products
with 100% quality. For this, the manufacturers of
injection moulding machines get together with
cleanroom specialists to offer a variety of cleanroom
solutions tailored to the article being produced and
factory conditions. A simple and inexpensive approach
is the mounting of a laminar-flow unit over the
clamping plates for the injection mould. This excludes
any exchange with unclean outside air. The injection
moulding machine itself stays in the gray room and the
injection mouldings are fed for further processing via
an airlock into the cleanroom proper. Even if a
cleanroom tent is placed over parts of the injection
moulder, the latter can still be operated from outside
the cleanroom. The most elaborate solution involves
the operation of the injection moulding machine in the
cleanroom itself. Along with operating staff wearing
special clothing, the machines and moulds themselves
are also potential sources of particulate
contaminants. The
all-electric injection moulding machines now rapidly
gaining ground can fully exploit their advantages
here. Compared to conventional hydraulic machines,
they generate barely any waste heat and, as a result
of their encapsulated drive units, are free of
lubricants and other abraded particles that might
contaminate the injection mouldings. |
Rexam Pharma GmbH, for instance,
appreciates the benefits of electric injection
moulding machines at its plant in Neuenburg (Germany).
The plant specialising entirely in the production of
medical and pharmaceutical articles operates with
almost one hundred injection moulding machines in a
cleanroom. Among them are EX fully electric injection
moulders from Krauss Maffei Technologies GmbH, Munich
(Germany). The managers value not only the machines’
reliability and cleanliness, but also their process
control which is more precise and easier to adjust
than that of hydraulic machines.

Cleanroom production at
Rexam at its Neuenburg plant: The all-electric
injection moulders are low-emission, precise and
therefore ideal for cleanroom production.
Mass Production With
Maximum Precision
|
Last year, at its Küssnacht
plant in Switzerland, Gerresheimer Medical Plastic
Systems also started gradually replacing its lines
for the production of cuvettes with new
high-performance equipment – including fully
electric Elion injection moulding machines from
Netstal-Maschinen AG, Näfels, Switzerland.
Gerresheimer manufactures these cuvettes on behalf
of a leading diagnostics group. These single-use
articles are employed in photometric laboratory
tests, among other things for identifying the
blood groups of donor or transfusion blood. The
optical components have to meet extreme quality
standards. They must not react with the test
substances employed nor show any shortcomings such
as impurities or scratches. Furthermore,
continuity of supplies must be assured, because
delivery bottlenecks might make the performance of
vital tests impossible. |

Within 0.25 seconds, this removal gripper
enters the injection mould, removes the pipettes
from a 32-cavity mould, carries out a presence
check and exits the mould.
Image: Hekuma

The 128- + 128-cavity
injection mould for the production of syringe
protectors features multiple cavities and
ingenious design.
Images: Schöttli |
Single-use medical articles are
items that are usually mass-produced fully
automatically and to an exceptionally high standard of
quality under 100% quality control. For production to
be cost-effective, every tenth of a second counts. The
manufacturers of the necessary automation systems are
constantly refining their handling strategies. The
requisite speed is provided by ever lighter and
slimmer removal systems with optimised drives. An
extremely fast cleanroom-compatible removal gripper
was launched by Hekuma GmbH, Eching (Germany), at the
end of 2009. What the supplier claims to be the
fastest removal system currently available for pipette
tips achieves with its linear axis acceleration rates
up to 10 g and travel speeds of up to 1,200 mm/s.
Within just 0.25 seconds, this removal gripper enters
the injection mould, removes the pipettes from a
32-cavity mould, carries out a presence check and
exits the mould again.
The injection moulds used for the
mass production of medical technology items also of
course have to be highly precise, cleanroom-compatible
and at the same time economical. Along with the
realisation of thin-walled products to save materials
and cycle time, there is also a demand for multiple
cavities and sophisticated cooling systems.
Multi-level moulds with up to 192 + 192 cavities are
made, for example, by the Swiss mouldmaker Schöttli AG
from Diessenhofen. Over 90 percent of their cleanroom-compatible
moulds for medical technology components are exported.
Injection Mouldings
In The Human Body
|
However, it is not only single-use items that
originate in the injection mould. For when it
comes to replacement parts for the human body,
injection moulding is a preferred process.
Particularly spectacular are “components” for use
in the inner organs. For instance, the
Moscow-based company Roscardioinvest produces a
new generation of tri-leaflet heart valves from a
modified polyamide. The mechanical heart valve
weighing only 0.25 g proved to be a severe test
for its developers. |

The new
generation of tri-leaflet heart valves can be
injection-moulded with the innovative Köbelin mould
without the need for downstream finishing.
Image: Köbelin |
|

Miniaturised guide element for stents
used in minimally invasive surgery.
Image: BCR The
main challenge was to design the mould in such a
way that the valves are free of sprue and ejector
marks. This is absolutely essential so that
neither clots nor turbulence can form at the
mechanical cardiac valve. Until now, the only way
to achieve this was by subsequently polishing the
valves. The world’s first mould for the fully
automatic, finishing-free injection moulding of
such heart valve leaflets has been developed and
made by Köbelin Formenbau GmbH, Eichstetten
(Germany). The mould was approved for series
production last year. |
|